NBIX Neurocrine Biosciences : Bullish and Bearish Analyst Opinions
Sentiment & Price
▼
Sentiment Gauge
0
Bull
0
Bear
0
Watch
Bull 50%
Bear 50%
Price & Sentiment
Loading chart...
Recent News
Top Views ▼
No recent news for NBIX
No theses available
Feed
01:26
Apr 07
Apr 07
Neurocrine's acquisition of Soleno adds a promising late-stage asset, providing strategic long-term growth for NBIX.
MED
About NBIX Analyst Coverage
Buzzberg tracks NBIX (Neurocrine Biosciences) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.